Convergent Validity of New Disease Assessment Instruments in Systemic Lupus Erythematosus in Relation to Sledai-2K

被引：0
|
作者：
Collins, Christopher [1 ]
Chatham, W. Winn [2 ]
Busch, Howard [3 ]
Gaylis, Norman B. [4 ]
Hautamaki, Emily [5 ]
Narayanan, Siva [6 ]
机构：
[1] MedStar Washington Hosp Ctr, Washington, DC USA
[2] Univ Alabama Birmingham, Med Clin Immunol & Rheumatol, Birmingham, AL USA
[3] Sci & Res Inst, Jupiter, FL USA
[4] Arthrit & Rheumat Dis Specialties, Aventura, FL USA
[5] Ipsos Healthcare, Washington, DC USA
[6] Ipsos Healthcare, Global Evidence Value & Access, Washington, DC USA
来源：
ARTHRITIS & RHEUMATOLOGY | 2015年 / 67卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
771
引用
收藏
页数：3
相关论文
共 50 条
  • [1] CONVERGENT VALIDITY OF NEW DISEASE ASSESSMENT INSTRUMENTS (DAI) IN SYSTEMIC LUPUS ERYTHEMATOSUS (SLE) IN RELATION TO SLEDAI-2K
    Narayanan, S.
    Collins, C. E.
    Busch, H. M.
    Gaylis, N.
    Hautamaki, E.
    Chatham, W. W.
    [J]. VALUE IN HEALTH, 2015, 18 (07) : A677 - A677
  • [2] RESPONSIVENESS AND TEST-RETEST RELIABILITY OF NEW DISEASE ASSESSMENT INSTRUMENTS IN SYSTEMIC LUPUS ERYTHEMATOSUS IN RELATION TO SLEDAI-2K
    Chatham, W. W.
    Collins, C. E.
    Gaylis, N.
    Busch, H.
    Hautamaki, E.
    Narayanan, S.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 657 - 658
  • [3] RESPONSIVENESS AND TEST-RETEST RELIABILITY OF NEW DISEASE ASSESSMENT INSTRUMENTS IN SYSTEMATIC LUPUS ERYTHEMATOSUS (SLE) IN RELATION TO SLEDAI-2K
    Narayanan, S.
    Busch, H. M.
    Collins, C. E.
    Chatham, W. W.
    DeLaRosa, O.
    Narvaez, M.
    Hautamaki, E.
    Gaylis, N.
    [J]. VALUE IN HEALTH, 2016, 19 (03) : A76 - A77
  • [4] CONVERGENT VALIDITY OF NEW DISEASE ASSESSMENT INSTRUMENTS IN SYSTEMIC LUPUS ERYTHEMATOSUS IN RELATION TO BILAG-2004
    Collins, C. E.
    Hautamaki, E.
    Narayanan, S.
    Busch, H. M.
    Lamichhane, D.
    Woodruff, L.
    Gaylis, N.
    Chatham, W. W.
    [J]. VALUE IN HEALTH, 2016, 19 (03) : A76 - A76
  • [5] The systemic lupus activity measure-revised, the Mexican systemic lupus erythematosus disease activity index (SLEDAI), and a modified SLEDAI-2K are adequate instruments to measure disease activity in systemic lupus erythematosus
    Uribe, AG
    Vilá, LM
    McGwin, G
    Sanchez, ML
    Reveille, JD
    Alarcón, GS
    [J]. JOURNAL OF RHEUMATOLOGY, 2004, 31 (10) : 1934 - 1940
  • [6] Evaluation of Systemic Lupus Erythematosus Disease Activity Index 2000 (SLEDAI-2K) vs. SLEDAI-2K Glucocorticoids (SLEDAI-2KG) on Patient Health-Related Quality of Life (HRQoL) in Systemic Lupus Erythematosus (SLE)
    Cheng, Alan
    Strand, Vibeke
    Su, Jiandong
    Anderson, Nicole
    Simon, Lee S.
    Touma, Zahi
    [J]. ARTHRITIS & RHEUMATOLOGY, 2022, 74 : 4132 - 4134
  • [7] VALIDATION OF SLEDAI-2K MODIFIED IN PATIENTS WITH CHILDHOOD-ONSET SYSTEMIC LUPUS ERYTHEMATOSUS
    Postal, M.
    Sinicato, N. A.
    Lapa, A. T.
    Pelicari, K. O.
    Marini, R.
    Appenzeller, S.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 : 1240 - 1240
  • [8] Association of disease activity with depression and anxiety in systemic lupus erythematosus: a comparison of SLEDAI-2K and SLE-DAS
    Yang, Leilei
    Gu, Bingjie
    Wang, Xiaoqin
    Ren, Qijie
    Shen, Minning
    Su, Dinglei
    [J]. RHEUMATOLOGY, 2024,
  • [9] Systemic Lupus Erythematosus Disease Activity Index (SLEDAI-2K) Responder Index (SRI)-50: a Valid Index for Measuring Improvement in Disease Activity
    Touma, Zahi
    Gladman, Dafna
    Ibanez, Dominique
    Urowitz, Murray
    [J]. JOURNAL OF RHEUMATOLOGY, 2011, 38 (06) : 1169 - 1170
  • [10] A Comparison of the Correlation of Systemic Lupus Erythematosus Disease Activity Index 2000 (SLEDAI-2K) and Systemic Lupus Erythematosus Disease Activity Score (SLE-DAS) with Health-Related Quality of Life
    Lai, Ning-Sheng
    Lu, Ming-Chi
    Chang, Hsiu-Hua
    Lo, Hui-Chin
    Hsu, Chia-Wen
    Huang, Kuang-Yung
    Tung, Chien-Hsueh
    Hsu, Bao-Bao
    Wu, Cheng-Han
    Koo, Malcolm
    [J]. JOURNAL OF CLINICAL MEDICINE, 2021, 10 (10)
12345